Search Within

Claire Frances Friedman

Formats
  1. Meeting Abstract (60)
  2. Journal Article (55)
  3. Editorial (2)
  4. Book Section (1)
  5. Guidelines (1)
  6. Research Letter (1)
  7. Review (1)
Groups
  1. Department of Medicine (121)
  2. GDMT, Medicine (121)
  3. Gynecologic Medicine Service (121)
  4. Gynecology Disease Management Team (121)
  5. Solid Tumor Oncology Division (121)
  6. Weinberg Fellows (121)

More Groups

People
  1. Carol Aghajanian (44)
  2. Dmitriy Zamarin (41)
  3. Britta Weigelt (32)
  4. Roisin O'Cearbhaill (30)
  5. Nadeem Abu-Rustum (27)
  6. Vicky Makker (26)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (11)
  4. 2022 (29)
  5. 2021 (12)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Gynecologic Oncology (18)
  3. Annals of Oncology (11)
  4. International Journal of Gynecological Cancer (10)
  5. Journal for ImmunoTherapy of Cancer (10)
  6. Clinical Cancer Research (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Elsevier B.V. (23)
  3. American Association for Cancer Research (15)
  4. Oxford University Press (14)
  5. Biomed Central Ltd (10)
  6. Lippincott Williams & Wilkins (10)

More Publishers

Results (121)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia
    Journal Article

    Freites-Martinez, A.; Navitski, A.; Friedman, C. F.; Chan, D.; Goldfarb, S.; Lacouture, M. E.; O'Cearbhaill, R. E.
    Gynecologic Oncology Reports (2022)

    Fulltext@MSK | Save
  • Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles
    Journal Article

    Manning-Geist, B. L.; Liu, Y. L.; Devereaux, K. A.; Da Cruz Paula, A.; Zhou, Q. C.; Ma, W.; Selenica, P.; Ceyhan-Birsoy, O.; Moukarzel, L. A.; Hoang, T.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Shared decision making in patients with breast and gynecologic malignancies receiving chemotherapy regimens associated with persistent alopecia
    Meeting Abstract

    Freites-Martinez, A.; O'Cearbhaill, R. E.; Friedman, C. F.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: A case series
    Journal Article

    Sia, T. Y.; Manning-Geist, B.; Gordhandas, S.; Murali, R.; Marra, A.; Liu, Y. L.; Friedman, C. F.; Hollmann, T. J.; Zivanovic, O.; Chi, D. S.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis
    Journal Article

    Gordhandas, S.; Schlappe, B. A.; Zhou, Q.; Iasonos, A.; Leitao, M. M. Jr; Park, K. J.; de Brot, L.; Alektiar, K. M.; Sabbatini, P. J.; Aghajanian, C. A.; more...
    Gynecologic Oncology Reports (2022)

    Fulltext@MSK | Save
  • DS-7300 (B7-H3 DXd-ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A subgroup analysis of a phase 1/2 multicenter study
    Meeting Abstract

    Patel, M. R.; Johnson, M. L.; Falchook, G. S.; Doi, T.; Friedman, C. F.; Piha-Paul, S. A.; Gutierrez, M.; Shimizu, T.; Cheng, B.; Qian, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Atezolizumab treatment of tumors with high tumor mutational burden from MyPathway, a multicenter, open-label, phase IIa multiple basket study
    Journal Article

    Friedman, C. F.; Hainsworth, J. D.; Kurzrock, R.; Spigel, D. R.; Burris, H. A. 3rd; Sweeney, C. J.; Meric-Bernstam, F.; Wang, Y.; Levy, J.; Grindheim, J.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • T cell intrinsic DNA damage and repair response as a novel marker associated with clinical response to PD-1 blockade
    Meeting Abstract

    Muroyama, Y.; Manne, S.; Greenplate, A.; Mathew, D.; Oldridge, D.; Chilukuri, L.; Xu, C.; Herati, R.; Huang, A.; Zamarin, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • MyPathway HER2 basket study: Pertuzumab (P) + trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors
    Meeting Abstract

    Meric-Bernstam, F.; Hainsworth, J.; Bose, R.; Burris, H. A. 3rd; Friedman, C. F.; Kurzrock, R.; Swanton, C.; Wang, Y.; Levy, J.; Schulze, K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save